175 related articles for article (PubMed ID: 6751073)
1. Hypertension in adult onset diabetes mellitus: abnormal renal hemodynamics and endogenous vasoregulatory factors.
Olshan AR; O'Connor DT; Cohen IM; Stone RA
Am J Kidney Dis; 1982 Sep; 2(2):271-80. PubMed ID: 6751073
[TBL] [Abstract][Full Text] [Related]
2. Reduced activity of the kallikrein-kinin system predominates over renin-angiotensin system overactivity in all conditions of sodium balance in essential hypertensives and family-related hypertension.
Sànchez R; Nolly H; Giannone C; Baglivo HP; Ramírez AJ
J Hypertens; 2003 Feb; 21(2):411-7. PubMed ID: 12569273
[TBL] [Abstract][Full Text] [Related]
3. Urinary kallikrein and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake.
Levy SB; Lilley JJ; Frigon RP; Stone RA
J Clin Invest; 1977 Jul; 60(1):129-38. PubMed ID: 874078
[TBL] [Abstract][Full Text] [Related]
4. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
[TBL] [Abstract][Full Text] [Related]
5. Increased urinary kallikrein excretion in young borderline hypertensive patients.
Ando K; Fujita T
Clin Exp Hypertens A; 1983; 5(6):903-18. PubMed ID: 6349868
[TBL] [Abstract][Full Text] [Related]
6. Non-modulating hypertension: evidence for the involvement of kallikrein/kinin activity associated with overactivity of the renin-angiotensin system. Successful blood pressure control during long-term Na+ restriction.
Sanchez R; Gimenez MI; Ramos F; Baglivo H; Ramirez AJ
J Hypertens; 1996 Nov; 14(11):1287-91. PubMed ID: 8934356
[TBL] [Abstract][Full Text] [Related]
7. Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension.
Sánchez RA; Marcó E; Gilbert HB; Raffaele P; Brito M; Giménez M; Moledo LI
Drugs; 1985; 30 Suppl 1():49-58. PubMed ID: 2994987
[TBL] [Abstract][Full Text] [Related]
8. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
Marzecka J
Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
[TBL] [Abstract][Full Text] [Related]
9. [Relation of atrial natriuretic peptide, the renin-angiotensin-aldosterone system and kinin system in hypertensive and normotensive youngsters with or without a family history of essential arterial hypertension].
Musca A; Ferri C; Cammerella I; Onofri R; Tani S; Santucci A
Medicina (Firenze); 1989; 9(2):167-72. PubMed ID: 2530412
[TBL] [Abstract][Full Text] [Related]
10. Relationships between renin, aldosterone, blood pressure and renal function in hypertensive insulin-dependent diabetes mellitus.
Winocour PH; Waldek S; Baker R
Diabetes Res Clin Pract; 1989 Aug; 7(2):99-108. PubMed ID: 2673711
[TBL] [Abstract][Full Text] [Related]
11. Urinary kallikrein in normal renin essential hypertension.
Lawton WJ; Fitz AE
Circulation; 1977 Nov; 56(5):856-9. PubMed ID: 912848
[TBL] [Abstract][Full Text] [Related]
12. Renal hemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with hypertensive and normotensive parents.
van Hooft IM; Grobbee DE; Derkx FH; de Leeuw PW; Schalekamp MA; Hofman A
N Engl J Med; 1991 May; 324(19):1305-11. PubMed ID: 2017226
[TBL] [Abstract][Full Text] [Related]
13. Effects of subpressor doses of angiotensin II on renal hemodynamics in relation to blood pressure.
Ljungman S; Aurell M; Hartford M; Wikstrand J; Berglund G
Hypertension; 1983; 5(3):368-74. PubMed ID: 6341220
[TBL] [Abstract][Full Text] [Related]
14. Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension.
Shoback DM; Williams GH; Moore TJ; Dluhy RG; Podolsky S; Hollenberg NK
J Clin Invest; 1983 Dec; 72(6):2115-24. PubMed ID: 6358261
[TBL] [Abstract][Full Text] [Related]
15. Urinary kallikrein in normotensive subjects and in patients with essential hypertension.
Zschiedrich H; Fleckenstein P; Geiger R; Fink E; Sinterhauf K; Philipp T; Distler A; Wolff HP
Clin Exp Hypertens (1978); 1980; 2(3-4):693-708. PubMed ID: 7000466
[TBL] [Abstract][Full Text] [Related]
16. Urinary kallikrein excretion in essential and mineralocorticoid hypertension.
Holland OB; Chud JM; Braunstein H
J Clin Invest; 1980 Feb; 65(2):347-56. PubMed ID: 7356684
[TBL] [Abstract][Full Text] [Related]
17. The effects of aprotinin, a kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives.
Madeddu P; Oppes M; Soro A; Dessi'-Fulgheri P; Glorioso N; Bandiera F; Manunta P; Rubattu S; Rappelli A
J Hypertens; 1987 Oct; 5(5):581-6. PubMed ID: 2448367
[TBL] [Abstract][Full Text] [Related]
18. Plasma and tissue kallikrein-kinin systems during acute administration of frusemide in normotensive and hypertensive humans.
Ohman KP; Karlberg BE
Clin Sci (Lond); 1991 Sep; 81(3):305-11. PubMed ID: 1655330
[TBL] [Abstract][Full Text] [Related]
19. [Correlations between circulation levels of natriuretic atrial peptide and urinary excretion of kallikrein in young normotensive and hypertensive subjects].
Ferri C; Cammarella I; Giarrizzo C; Bellini C; Astorre P; Di Zenzo P; Santucci A; Musca A; Balsano F
Ann Ital Med Int; 1991; 6(2):217-23. PubMed ID: 1836137
[TBL] [Abstract][Full Text] [Related]
20. Decreased urinary kallikrein with hyperglycemia in patients with short-term insulin-dependent diabetes mellitus.
Pelikánová T; Pinsker P; Smrcková I; Stribrná L; Dryáková M
J Diabetes Complications; 1998; 12(5):264-72. PubMed ID: 9747643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
